Biological Characterization of TAK-901, an Investigational, Novel, Multitargeted Aurora B Kinase InhibitorPamela Farrell, Ron de Jong, Lihong Shi et al.|Molecular Cancer Therapeutics|2013Cited by 46
The Investigational Multi-Targeted Kinase Inhibitor TAK-901 Antagonizes Acute Myeloid Leukemia Pathogenesis: Results of Preclinical StudiesPatrick R. Griffin, Jennifer S. Carew, Angela Romanelli et al.|Blood|2011Cited by 1
Abstract C193: Biological evaluation of novel multi-targeted Aurora-B kinase inhibitor TAK-901 in xenograft modelsTakashi Satou, Ron de Jong, Takashi Hoshino et al.|Molecular Cancer Therapeutics|2009Cited by 0